Abstract
Chronic obstructive pulmonary disease is one of the most common disease affecting millions of people worldwide. It is a multicomponent disease which beside airflow obstruction causes airway inflammation, structural changes, mucociliary dysfunction and systemic dysfunction. Airway responsiveness is altered during sleep along with decrease in ventilation due to reduction in tidal volume. Patients with COPD also develop significant nocturnal desaturation despite adequate oxygenation during the wake state. Almost 14% of patients with COPD also have concurrent obstructive sleep apnea, which in turn can lead to more desaturation, hypoxia and hypercarbia. The COPD can affect the quality of life by causing insomnia, excessive day time sleepiness, fatigue, morning awakening, and poor sleep quality. In the current article we will address the issues of oxygenation during sleep, effects of combination of COPD and OSA, quality of sleep in COPD patients and different therapeutic options to counter the effects of COPD on sleep.
Keywords: Obstructive sleep apnea, sleep and COPD, sleep in medical disorder
Current Respiratory Medicine Reviews
Title: Sleep and COPD
Volume: 5 Issue: 4
Author(s): Salim Surani
Affiliation:
Keywords: Obstructive sleep apnea, sleep and COPD, sleep in medical disorder
Abstract: Chronic obstructive pulmonary disease is one of the most common disease affecting millions of people worldwide. It is a multicomponent disease which beside airflow obstruction causes airway inflammation, structural changes, mucociliary dysfunction and systemic dysfunction. Airway responsiveness is altered during sleep along with decrease in ventilation due to reduction in tidal volume. Patients with COPD also develop significant nocturnal desaturation despite adequate oxygenation during the wake state. Almost 14% of patients with COPD also have concurrent obstructive sleep apnea, which in turn can lead to more desaturation, hypoxia and hypercarbia. The COPD can affect the quality of life by causing insomnia, excessive day time sleepiness, fatigue, morning awakening, and poor sleep quality. In the current article we will address the issues of oxygenation during sleep, effects of combination of COPD and OSA, quality of sleep in COPD patients and different therapeutic options to counter the effects of COPD on sleep.
Export Options
About this article
Cite this article as:
Surani Salim, Sleep and COPD, Current Respiratory Medicine Reviews 2009; 5 (4) . https://dx.doi.org/10.2174/157339809790112465
DOI https://dx.doi.org/10.2174/157339809790112465 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Update on Cardiovascular Effects of Older and Newer Anti-diabetic Medications
Current Medicinal Chemistry Subject Index To Volume 6
Current Gene Therapy Editorial [Hot Topic: Metabolic Syndrome in an Asian Chinese Population and Agents and Targets for Cardiovascular Protection (Guest Editors: M.L. Fung and T.M. Wong)]
Cardiovascular & Hematological Disorders-Drug Targets Role of Asymmetric Dimethylarginine (ADMA) in Diabetic Vascular Complications
Current Pharmaceutical Design Pharmacological Effects of Biotin in Animals
Mini-Reviews in Medicinal Chemistry ACE and ACE2 in Inflammation: A Tale of Two Enzymes
Inflammation & Allergy - Drug Targets (Discontinued) Drug Therapy Aimed at Adenylyl Cyclase to Regulate Cyclic Nucleotide Signaling
Endocrine, Metabolic & Immune Disorders - Drug Targets Bruton Kinase Inhibitors in Chronic Lymphocytic Leukemia
Anti-Cancer Agents in Medicinal Chemistry Stress and Physical Inactivity: Two Explosive Ingredients for the Heart in COVID-19 Pandemic Times
Current Cardiology Reviews Intravitreal Triamcinolone in Diabetic Retinopathy
Current Diabetes Reviews Do Human Lipoxygenases have a PDZ Regulatory Domain?
Current Molecular Medicine Role of ω3 Longchain Polyunsaturated Fatty Acids in Reducing Cardio- Metabolic Risk Factors
Endocrine, Metabolic & Immune Disorders - Drug Targets Large A-V Fistula: Pathophysiological Consequences and Therapeutic Perspectives
Current Vascular Pharmacology Alzheimer’s Disease and Retinal Degeneration: A Glimpse at Essential Trace Metals in Ocular Fluids and Tissues
Current Alzheimer Research Adverse Effects of Mineralocorticoid Receptor Antagonist Administration
Current Pharmaceutical Design A Systematic Review of First Trimester Biochemical and Molecular Predictive Tests for Preeclampsia
Current Hypertension Reviews Perioperative Management of Intracranial Aneurysm and Subarachnoid Hemorrhage
Current Pharmaceutical Design Drugs as Possible Triggers of Takotsubo Cardiomyopathy: A Comprehensive Literature Search - Update 2015
Current Clinical Pharmacology Promotion of Insulin-Like Growth Factor-I Production by Sensory Neuron Stimulation; Molecular Mechanism(s) and Therapeutic Implications
Current Medicinal Chemistry Toxicity by NSAIDs. Counteraction by Stable Gastric Pentadecapeptide BPC 157
Current Pharmaceutical Design